Wage arrears rise, INAF reveals divestment progress
18 days ago
INAF is selling assets to settle employee wages of IDR 98.93 billion. Is the asset value sufficient?
INAF sells assets for IDR312.94 billion to pay for employee rightsizing and debt
4 months ago
PT Indofarma announced that it will sell its assets worth around IDR 312.94 billion consisting of land and buildings located in 10 provinces in Indonesia.
Indofarma to divest jumbo assets; what could be behind it?
4 months ago
PT Indofarma Tbk (INAF) is reportedly planning to divest over 50% of company assets, according to the report received by IDNFinancials from Indonesia Stock Exchange (IDX) last Thursday (12/12).
Employee's wages in arrears, Indofarma to divest assets
7 months ago
PT Indofarma Tbk (INAF), a state-owned medicine and medical device manufacturer, is said to sell off its remaining assets to pay arrears to its own employees.
Indofarma still on loss streak until H1 2024
8 months ago
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
Official, shareholders approve INAF’s 50%-of-assets guarantee
a year ago
The shareholders of PT Indofarma Tbk (INAF) has agreed upon the guarantee of over 50% of net assets of the company as a collateral for the company’s obligation.